Open Label Single Arm Prebiotic Pilot Trial SR001

NAActive, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

July 1, 2025

Study Completion Date

November 30, 2025

Conditions
PARKINSON DISEASE (Disorder)
Interventions
DIETARY_SUPPLEMENT

Prebiotic fiber blend

"Proprietary blend of 5 prebiotic fibers and normal bar excipients Product name: NeuroFiber Dosage form: Single bar/day~Storage conditions:~The Study Product delivered by Sorridi to patient/subject at the beginning of study. Any remainder will be collected by Sorridi at end of study.~Product is to be stored at room temperature in the patient's/subject's homes.~The bar will be produced and packaged at a licensed contract manufacturer experienced in producing nutritional supplements.~Labelling will be carried out by Sorridi Therapeutics."

Trial Locations (1)

60062

Sorridi Therapeutics, Northbrook

All Listed Sponsors
collaborator

Illinois Institute of Technology, Chicago, USA

UNKNOWN

lead

Sorridi Therapeutics

INDUSTRY

NCT07127120 - Open Label Single Arm Prebiotic Pilot Trial SR001 | Biotech Hunter | Biotech Hunter